1Paediatric Intensive Care Unit, Royal Children's Hospital, Melbourne, Australia. 2Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China. 3Cardiothoracic Intensive Care Unit, National University Health System, Singapore. 4Department of Paediatrics, University of Melbourne, Melbourne, Australia. 5Murdoch Children's Research Institute, Melbourne, Australia.
Crit Care Med. 2014 May;42(5):1213-20. doi: 10.1097/CCM.0000000000000128.
To explore the prevalence and risk factors for hemolysis in children receiving extracorporeal membrane oxygenation and examine the relationship between hemolysis and adverse outcomes.
Retrospective, single-center study.
Tertiary PICU.
Two hundred seven children receiving extracorporeal membrane oxygenation.
None.
Plasma-free hemoglobin was tested daily and hemolysis was diagnosed based on peak plasma-free hemoglobin as mild (< 0.5 g/L), moderate (0.5-1.0 g/L), or severe (> 1.0 g/L). Gender, age, weight, diagnosis, oxygenator type, cannulation site, mean venous inlet pressure, mean pump speed, mean flow, and visible clots in the extracorporeal membrane oxygenation circuit were entered into the ordered logistic regression model to identify risk factors of hemolysis. Complications and clinical outcomes were compared across four hemolysis groups. Of the 207 patients, 69 patients (33.3%; 95% CI, 27.0-40.2%) did not have hemolysis, 98 patients (47.3%; 95% CI, 40.4-54.4%) had mild hemolysis, 26 patients (12.5%; 95% CI, 8.4-17.9%) had moderate hemolysis, and 14 patients (6.8%; 95% CI, 3.7-11.1%) had severe hemolysis with a median peak plasma-free hemoglobin of 1.51 g/L (1.18-2.05 g/L). The independent risk factors for hemolysis during extracorporeal membrane oxygenation were use of Quadrox D (odds ratio, 7.25; 95% CI, 3.10-16.95; p < 0.001) or Lilliput (odds ratio, 37.32; 95% CI, 8.95-155.56; p < 0.001) oxygenators, mean venous inlet pressure (odds ratio, 0.95; 95% CI, 0.91-0.98; p = 0.002), and mean pump speed (odds ratio, 2.89; 95% CI, 1.36-6.14; p = 0.006). Patients with hemolysis were more likely to experience a longer extracorporeal membrane oxygenation run and require more blood products. After controlling for age, weight, pediatric index of mortality 2, and diagnosis, patients with severe hemolysis were more likely to die in the ICU (odds ratio, 5.93; 95% CI, 1.64-21.43; p = 0.007) and in hospital (odds ratio, 6.34; 95% CI, 1.71-23.54; p = 0.006).
Hemolysis during extracorporeal membrane oxygenation with centrifugal pumps was common and associated with a number of adverse outcomes. Risk factors for hemolysis included oxygenator types, mean venous inlet pressure, and mean pump speed. Further studies are warranted comparing pump types while controlling both physical and nonphysical confounders.
探讨体外膜肺氧合(ECMO)患儿发生溶血的患病率和危险因素,并研究溶血与不良结局之间的关系。
回顾性、单中心研究。
三级儿科重症监护病房(PICU)。
接受 ECMO 的 207 例患儿。
无。
每天检测血浆游离血红蛋白,并根据峰值血浆游离血红蛋白将溶血诊断为轻度(<0.5 g/L)、中度(0.5-1.0 g/L)或重度(>1.0 g/L)。将性别、年龄、体重、诊断、氧合器类型、插管部位、平均静脉入口压力、平均泵速、平均流量以及 ECMO 回路中可见的凝块等因素纳入有序逻辑回归模型,以确定溶血的危险因素。比较了四个溶血组的并发症和临床结局。在 207 例患者中,69 例(33.3%;95%置信区间,27.0-40.2%)未发生溶血,98 例(47.3%;95%置信区间,40.4-54.4%)发生轻度溶血,26 例(12.5%;95%置信区间,8.4-17.9%)发生中度溶血,14 例(6.8%;95%置信区间,3.7-11.1%)发生重度溶血,中位峰值血浆游离血红蛋白为 1.51 g/L(1.18-2.05 g/L)。ECMO 期间发生溶血的独立危险因素包括使用 Quadrox D(比值比,7.25;95%置信区间,3.10-16.95;p<0.001)或 Lilliput(比值比,37.32;95%置信区间,8.95-155.56;p<0.001)氧合器、平均静脉入口压力(比值比,0.95;95%置信区间,0.91-0.98;p=0.002)和平均泵速(比值比,2.89;95%置信区间,1.36-6.14;p=0.006)。发生溶血的患者更有可能经历较长时间的 ECMO 运行并需要更多的血液制品。在控制年龄、体重、儿科死亡率 2 指数和诊断后,发生重度溶血的患者更有可能在 ICU 内死亡(比值比,5.93;95%置信区间,1.64-21.43;p=0.007)和住院期间死亡(比值比,6.34;95%置信区间,1.71-23.54;p=0.006)。
离心式 ECMO 泵治疗期间发生溶血较为常见,并与多种不良结局相关。溶血的危险因素包括氧合器类型、平均静脉入口压力和平均泵速。进一步的研究需要比较不同泵类型,同时控制物理和非物理混杂因素。